Powered by CureScience Institute, CureInnovation is an incubator focused on supporting early-stage innovators working at the intersection of biotechnology, precision medicine, AI, translational research, and patient-centered healthcare.
We partner with emerging founders, scientists, clinicians, and mission-driven startups to help accelerate promising ideas into real-world impact.
Through strategic guidance, scientific collaboration, operational support, and access to an expanding network of researchers, clinicians, and industry partners, CureInnovation helps breakthrough ideas move forward faster.
Our goal is simple: To support the next generation of innovators working to improve patient outcomes and advance the future of medicine.
Venture Philanthropy: Investing in Innovation
Promising scientific discoveries often face significant challenges securing the resources needed to advance from research to clinical application.
Through CureInnovation’s venture philanthropy initiative, CureScience brings together philanthropic support, scientific expertise, and strategic investments to help emerging biotechnology companies develop technologies with the potential to improve patient care.
Unlike traditional philanthropy, venture philanthropy allows us to support promising companies while potentially retaining an equity interest in their future success.
Any financial returns to CureScience can be reinvested into our nonprofit mission, supporting additional research, innovation, and the next generation of scientific breakthroughs.
During a CureInsights call, we:
CureSeek is an AI-powered second opinion platform that synthesizes your scans, pathology, genomics, and history with the latest oncology research, surfacing personalized, evidence-backed treatment options for you and your care team.
Advancing a novel dual-action therapy designed to halt recurrence by eradicating cancer stem cells and reversing tumor-driven immune suppression in adult and pediatric brain cancers.
Developing a non-invasive medical device that reversibly opens the blood-brain barrier precisely where it is needed.
Next-generation platform designed to help scale precision medicine, translational research, and patient-centered innovation beyond the traditional research model. While still in stealth development, these efforts reflect our commitment to building practical infrastructure that can accelerate how promising science reaches the real world.
MD2 Biosciences is a biopharmaceutical company focused on discovering, developing, and commercializing therapeutics in the area of oncology. We are pursuing product candidates with a strong scientific rationale to address a high unmet need in oncology and an opportunity to develop best-in-class or first-in-class programs.
Our Innovation Portfolio
CureScience is already supporting emerging biotechnology companies developing new approaches to precision medicine, therapeutics, diagnostics, and medical technologies.
Through CureInnovation, we continue to identify opportunities to collaborate with promising innovators, support their development, and help advance technologies that could make a meaningful difference for patients.
Support CureInnovation
Your gift can help advance the next generation of medical breakthroughs.
Philanthropic contributions to CureInnovation support CureScience Institute’s efforts to advance promising early-stage biotechnology companies, scientific discoveries, and emerging medical technologies.
Your generosity helps provide the resources, expertise, and support needed to move promising innovations forward.
Make a Gift
For information about major gifts, strategic partnerships, or supporting a specific initiative, please contact CureScience Institute.
Supporting promising companies and technologies that need resources to advance their development.
Helping emerging companies navigate research, development, partnerships, and commercialization opportunities.
Connecting innovators with researchers, clinicians, and scientific experts.
Building relationships with innovative companies whose success may generate additional resources to advance CureScience's mission.
Our Innovation Portfolio
CureScience is already supporting emerging biotechnology companies developing new approaches to precision medicine, therapeutics, diagnostics, and medical technologies.
Through CureInnovation, we continue to identify opportunities to collaborate with promising innovators, support their development, and help advance technologies that could make a meaningful difference for patients.
Support CureInnovation
Your gift can help advance the next generation of medical breakthroughs.
Philanthropic contributions to CureInnovation support CureScience Institute’s efforts to advance promising early-stage biotechnology companies, scientific discoveries, and emerging medical technologies.
Your generosity helps provide the resources, expertise, and support needed to move promising innovations forward.
Make a Gift
For information about major gifts, strategic partnerships, or supporting a specific initiative, please contact CureScience Institute.
Supporting promising companies and technologies that need resources to advance their development.
Connecting innovators with researchers, clinicians, and scientific experts.
Helping emerging companies navigate research, development, partnerships, and commercialization opportunities.
Building relationships with innovative companies whose success may generate additional resources to advance CureScience's mission.
